rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2004-11-12
|
pubmed:abstractText |
Phagocytosis of apoptotic cells usually results in an anti-inflammatory state with inhibition of proinflammatory cytokines such as IL-12. How apoptotic cell-derived signals regulate IL-12 gene expression is not understood. We demonstrate that cell-cell contact with apoptotic cells is sufficient to induce profound inhibition of IL-12 production by activated macrophages. Phosphatidylserine could mimic the inhibitory effect. The inhibition does not involve autocrine or paracrine actions of IL-10 and TGF-beta. We report the identification, purification, and cloning of a novel zinc finger nuclear factor, named GC binding protein (GC-BP), that is induced following phagocytosis of apoptotic cells by macrophages or by treatment with phosphatidylserine. GC-BP selectively inhibits IL-12 p35 gene transcription by binding to its promoter in vitro and in vivo, thus decreasing IL-12 production. Blocking GC-BP by RNA interference restores IL-12 p35 transcription and IL-12 p70 synthesis. Finally, GC-BP itself undergoes functionally significant tyrosine dephosphorylation in response to apoptotic cells.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/C2orf3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/IL12A protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-12,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-12 Subunit p35,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Subunits,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Repressor Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/TGFB1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1074-7613
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
643-53
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15539151-Apoptosis,
pubmed-meshheading:15539151-Cell Communication,
pubmed-meshheading:15539151-Cells, Cultured,
pubmed-meshheading:15539151-Humans,
pubmed-meshheading:15539151-Interleukin-12,
pubmed-meshheading:15539151-Interleukin-12 Subunit p35,
pubmed-meshheading:15539151-Phagocytosis,
pubmed-meshheading:15539151-Phosphorylation,
pubmed-meshheading:15539151-Promoter Regions, Genetic,
pubmed-meshheading:15539151-Protein Subunits,
pubmed-meshheading:15539151-RNA, Messenger,
pubmed-meshheading:15539151-Repressor Proteins,
pubmed-meshheading:15539151-Transcription, Genetic,
pubmed-meshheading:15539151-Transforming Growth Factor beta,
pubmed-meshheading:15539151-Transforming Growth Factor beta1
|
pubmed:year |
2004
|
pubmed:articleTitle |
Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells.
|
pubmed:affiliation |
Department of Microbiology and Immunology, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10021, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|